Global Myocardial Perfusion Imaging (MPI) Testing Market Size, Status and Forecast 2019-2025

SKU ID : QYR-14457845 | Publishing Date : 17-Jul-2019 | No. of pages : 97

Myocardial perfusion imaging is an imaging device which work non-invasively to show the blood flow, myocardial perfusion imaging also known as nuclear cardiology test. The main function of this imaging to show the blood flow to muscle of heart or myocardium and to identify the absence or presence of CAD (coronary artery disease). Myocardial perfusion imaging show 3D image. Myocardial perfusion imaging two technique, such as PET (positron emission tomography) and SPECT (single photon emission computed tomography). Myocardial perfusion imaging is useful in checking of chest discomfort for facing problem in blood flow to muscle of heart that is caused by angina (blocked in heart arteries) or by narrow in the arteries vessels. The myocardial perfusion imaging process as a small amount of radioactive material is injected that can travel to muscle of heart, then the scan process started to monitor the flow. The Myocardial perfusion imaging testing manage to treat the CAD (coronary artery disease) for medical therapy and revascularization process.
North America is holding the major segment of the market.
In 2018, the global Myocardial Perfusion Imaging (MPI) Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Myocardial Perfusion Imaging (MPI) Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Myocardial Perfusion Imaging (MPI) Testing development in United States, Europe and China.

The key players covered in this study
Siemens
Koninklijke Philips
Convergent Imaging
SurgicEye GmbH
Lantheus Medical Imaging
Spectrum Dynamics Medical
...

Market segment by Type, the product can be split into
Stress Myocardial Perfusion Imaging (MPI)
Resting Myocardial Perfusion Imaging (MPI)

Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgery Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Myocardial Perfusion Imaging (MPI) Testing status, future forecast, growth opportunity, key market and key players.
To present the Myocardial Perfusion Imaging (MPI) Testing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Myocardial Perfusion Imaging (MPI) Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
market Reports market Reports